Tag: pfizer

FDA Knew About Numerous Adverse Events For Children ‘Related’ To Pfizer Vaccine, Approved It Anyway

Here is the “Vaccines and Related Biological Products Advisory Committee Meeting October 26, 2021 Briefing Document” published by the FDA. Page 15 lists an “OVERVIEW OF CLINICAL STUDIES.” Two clinical studies are listed. The first clinical study listed is “Phase 1/2/3 Registrational Study C4591001,” which was sponsored by BioNTech and conducted by Pfizer. The other clinical study listed is “Phase 1/2/3 Pediatric Study C4591007,” which is listed as being sponsored by BioNTech and supported by Pfizer. “Pediatric Study c4591007” is an ongoing study and it was used by the FDA for approval of the vaccine for ages 5 to 12. That’s right. The FDA meeting’s data was taken from an ongoing study conducted by the very makers of the vaccine. The information below comes from the FDA Briefing Packet’s review of Pfizer Pediatric Study C4591007.

Keep reading

British Medical Journal Publishes Damning Report Claiming Pfizer Faked Vaccine Data in Trials

Leading medical journal The BMJ has published an incendiary report exposing faked data, blind trial failures, poorly trained vaccinators, and a slow follow-up on adverse reactions in the phase-three trial of Pfizer’s Covid jab.

Central to the exposé is Brook Jackson, who, for two weeks, served as regional director at Ventavia Research Group, the company contracted to assist with the pivotal trial. She provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails supporting her concerns.

Jackson reveals that Ventavia staff who conducted quality-control checks were overwhelmed by the volume of problems they were identifying. She repeatedly informed her superiors of poor laboratory management, and patient safety and data integrity issues.

In a cited internal document from August 2020, shortly after the Pfizer trial began, a Ventavia executive identified three site staff members with whom to “go over e-diary issue/falsifying data, etc.” One employee was said to have been subsequently “verbally counseled for changing data” and “not noting late entry.”

Jackson reported her concerns to the US Food and Drug Administration (FDA), but was fired later the same day on the basis that she was “not a good fit.”

Keep reading

Disturbing Pfizer Ad Tells Kids They’ll Get Superpowers from COVID Jab

Pfizer was given the go-ahead this week from the CDC to give the experimental COVID vaccine to children.

Children have a greater chance of drowning, dying in a car wreck or dying from the flu than from the coronavirus.
Children are not forced to take the flu vaccine.

More children in Chicago have been shot this year than died from the coronavirus across the country.

But Pfizer sees a new market potential of one billion humans for their experimental product. And they’re going for it.

Keep reading

FDA Admits MORE Serious Adverse Effects From Pfizer Vaccine ‘May Become Apparent’ With Widespread Use

A Fact Sheet for Vaccine Providers published on the Food and Drug Administration (FDA) website admits that “Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.” The Fact Sheet was issued in response to the FDA granting an emergency use authorization for the Pfizer vaccine for people aged 12 and older. The Fact Sheet also notes that the Pfizer vaccine carries risk of the heart conditions myocarditis and pericarditis in addition to numerous other ailments that have been reported in clinical trials, and that “immunocompromised persons…may have a diminished immune response to the Pfizer-BioNTech COVID-19 Vaccine.” Recent former FDA commissioner Scott Gottlieb (pictured above) is now on the board of directors of Pfizer. A contingent of recent Pfizer workers who serve on an FDA advisory committee are trying to get the FDA to authorize a Pfizer vaccine for children aged 5 to 11.

Keep reading

FDA Committee Members Reviewing Pfizer Vaccine For Children Have Worked For Pfizer, Have Big Pfizer Connections

The FDA’s Vaccines and Related Biological Products Advisory Committee is holding a virtual meeting Tuesday October 26 to discuss authorizing a Pfizer-BioNTech Coronavirus vaccine for children between the ages of 5 to 11 years old.

This committee has a lot of sway with the FDA and their findings will be relevant, considering the Biden administration is getting ready to ship vaccines to elementary schools and California has already mandated the vaccine for schoolchildren pending federal authorization.

But the meeting roster shows that numerous members of the committee and temporary voting members have worked for Pfizer or have major connections to Pfizer.

Members include a former vice president of Pfizer Vaccines, a recent Pfizer consultant, a recent Pfizer research grant recipient, a man who mentored a current top Pfizer vaccine executive, a man who runs a center that gives out Pfizer vaccines, the chair of a Pfizer data group, a guy who was proudly photographed taking a Pfizer vaccine, and numerous people who are already on the record supporting Coronavirus vaccines for children. Meanwhile, recent FDA Commissioner Scott Gottlieb is on Pfizer’s board of directors.

HERE’S THE MEETING ROSTER: Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Draft Roster.

Keep reading

Pfizer Scientist Flees After Being Caught On Tape Admitting COVID Antibodies Are Better Than Vaccines

Pfizer scientist Nick Karl, who privately admitted COVID antibodies are better than his company’s vaccine, was questioned by Project Veritas founder James O’Keefe while in public.

Nick Karl, who was not wearing a mask despite appearing to sit in a restaurant, was visibly surprised and upset when confronted by Project Veritas. He acknowledged his name, then became startled and refused to speak to O’Keefe as he abruptly rose and left the building.

Karl questioned, “I’m not doing this. Do not, absolutely not, what are you doing right now?” He then demanded to see video proving O’Keefe’s claims. When O’Keefe presented a tablet to view them, Karl fled the restaurant to his vehicle and drove away.

Karl, described by Project Veritas as an “experienced biochemist at Pfizer” with a history in pharmaceuticals, was caught in undercover video claiming that natural immunity provides a more robust antibody response to COVID-19 than the Pfizer vaccine.

“It’s just one antibody against one specific part of the virus,” said Karl while being recorded by a Project Veritas journalist. “When you actually get the virus, you’re going to start producing antibodies against like multiple pieces of virus.” Project Veritas also recorded two other Pfizer scientists who agree with this assessment.

Keep reading

Pfizer stand accused of experimenting on orphan babies to test their Covid-19 vaccine

Allegations that Pfizer are conducting experiments on six-month-old orphans to test their Covid-19 vaccine have been made by whistleblowers in Poland leading to a group of lawyers, medical professionals and activists demanding members of the Polish parliament and Senate organise an urgent conference on Saturday 2nd October.

Children’s Health Defense was recently alerted by Polish whistleblowers that Pfizer is conducting experiments on orphan babies 6 months old to test their new vaccines. Babies and children do not die from Covid and rarely transmit the disease. This alone should be enough to refuse any kind of clinical trials with experimental vaccines.  But Pfizer seems to be operating outside legal boundaries. If this is case, it is simply unacceptable and needs to stop. Answers and action are needed.

Keep reading

Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To ‘Horse Paste’

Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that it’s launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease.

Coincidentally (or not), Pfizer’s drug shares at least one mechanism of action as Ivermectin – an anti-parasitic used in humans for decades, which functions as a protease inhibitor against Covid-19, which researchers speculate “could be the biophysical basis behind its antiviral efficiency.”

Lo and behold, Pfizer’s new drug – which some have jokingly dubbed “Pfizermectin,” is described by the pharmaceutical giant as a “potent protease inhibitor.”

As Zero Hedge readers might recognize, that’s exactly what ivermectin, the prophylactic used for a number of reasons in both humans and animals, does. And unlike Pfizer’s experimental drug, ivermectin already may have saved hundreds of thousands of lives from India to Brazil.

We aren’t the only ones to have put this together, as twitter users have commented on the similarities. The timing – which coincides with the whole “horse dewormer” smear campaign – just seems odd.

The similarity between Pfizer’s upcoming offering and Ivermectin has not gone unnoticed.

Keep reading

Pfizer Is Now Developing A Twice-Per-Day COVID Pill That Must Be Taken Alongside Vaccines

Pharmaceutical megacorporation pfizer is now developing a COVID pill that is meant to be taken alongside the COVID vaccines that have already made the company a staggering amount of money. The new pill is expected to be released by the end of the year and will be required to be taken twice per day.

“Success against #COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Wednesday. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”

Pfizer also put out a press release the same week that proclaimed, “If successful, [the drug] has the potential to address a significant unmet medical need, providing patients with a novel oral therapy that could be prescribed at the first sign of infection, without requiring hospitalization.” The company described the drug as an “investigational orally administered protease inhibitor antiviral therapy designed specifically to combat COVID–19 – in non–hospitalized, symptomatic adult participants who have a confirmed diagnosis of SARS–CoV–2 infection and are not at increased risk of progressing to severe illness, which may lead to hospitalization or death.”

Media corporations have already expressed excitement about the new pill, and Pfizer is so confident that the pill will be swiftly approved and mandated by governments that it has already started a production line before the end of clinical trials.

Keep reading